Harel Insurance Investments & Financial Services Ltd. sells 6,352 shares of Colgate-Palmolive (NYSE:CL)


Harel Insurance Investments & Financial Services Ltd. decreased its holdings in Colgate-Palmolive (NYSE:CL – Get Rating ) by 88.1% during the first quarter, HoldingsChannel.com reports. The fund owned 857 shares of the company’s stock after selling 6,352 shares during the period. The holdings of Harel Insurance Investments & Financial Services Ltd. in Colgate-Palmolive were worth $65,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Horan Securities Inc. bought a new position in Colgate-Palmolive in the fourth quarter valued at about $30,000. TAP Consulting LLC bought a new position in Colgate-Palmolive in the fourth quarter valued at about $40,000. Widmann Financial Services Inc. bought a new position in Colgate-Palmolive in the fourth quarter valued at about $42,000. Riverview Trust Co bought a new position in Colgate-Palmolive in the first quarter valued at about $38,000. Finally, Shore Point Advisors LLC purchased a new position in Colgate- Palmolive in the fourth quarter, valued at about $43,000. The institutional investor owned 78.12% of the company’s stock.

Insider Buying and Selling at Colgate-Palmolive

In other news, insider John W. Koiman sold 19,683 shares of the business’s stock in a transaction that occurred on Monday, May 16th. The shares were sold at an average price of $78.49, for a total transaction of $1,544,918.67. Following the completion of the sale, the insider now owns 7,007 shares in the company, valued at $549,979.43. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, insider John W. Koiman sold 19,683 shares of the business’s stock in a transaction that occurred on Monday, May 16th. The shares were sold at an average price of $78.49, for a total transaction of $1,544,918.67. Following the completion of the sale, the insider now owns 7,007 shares in the company, valued at $549,979.43. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, VP Philip G. Shotts sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, May 16th. The shares were sold at an average price of $78.52, for a total value of $785,200.00. Following the sale, the vice president now owns 46,094 shares of the company’s stock, valued at approximately $3,619,300.88. Disclosure of this sale can be found here. Over the last three months, insiders have sold 79,683 shares of company stock worth $6,297,119. 0.31% of shares are currently owned by company insiders.

Promote and demote an analyst

CL has been the subject of a number of recent research reports. Atlantic Securities downgraded Colgate-Palmolive from an “overweight” rating to a “neutral” rating and cut their target price for the company from $92.00 to $80.00 in a research note on Tuesday, May 3rd. Barclays cut their target price on Colgate-Palmolive from $77.00 to $71.00 and set an “equal weight” rating on the stock in a research note on Monday, May 23rd. StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Wednesday, April 13th. Deutsche Bank Aktiengesellschaft reduced their target price on Colgate-Palmolive from $88.00 to $87.00 in a research note on Tuesday, July 19th. Finally, TheStreet upgraded Colgate-Palmolive from a “c+” rating to a “b” rating in a research note on Friday, April 29th. One analyst has rated the stock with a sell rating, thirteen have given a hold rating and two have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average price target of $83.93, based on data from MarketBeat.

Colgate-Palmolive pricing performance

Shares of CL stock opened at $77.47 on Monday. Colgate-Palmolive has a 52-week low of $72.20 and a 52-week high of $85.61. The company has a debt-to-equity ratio of 10.42, a quick earnings ratio of 0.67 and a current ratio of 1.09. The business’s 50-day moving average is $77.88, and its 200-day moving average is $78.51. The firm has a market cap of $64.92 billion, a PE ratio of 32.01, a price-to-earnings-growth ratio of 5.53 and a beta of 0.51.

Colgate-Palmolive (NYSE:CL – Get Rating ) last posted its quarterly earnings results on Friday, April 29th. The company reported $0.74 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.74. Colgate-Palmolive had a return on equity of 296.77% and a net margin of 11.70%. The firm had revenue of $4.40 billion for the quarter, compared to analyst estimates of $4.40 billion. During the same period in the prior year, the firm earned $0.80 earnings per share. The company’s revenue was up 1.3% compared to the same quarter last year. On average, equities analysts expect that Colgate-Palmolive will post 3.04 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, August 15th. Shareholders of record on Thursday, July 21st will be given a $0.47 dividend. This represents a $1.88 annual dividend and a yield of 2.43%. The ex-dividend date is Wednesday, July 20th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 77.69%.

Colgate-Palmolive Company Profile

(Get Rating)

The Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates in two segments, Oral, Personal and Home Care; and Pet Food. The Oral, Personal and Home Care segment offers toothpastes, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents , fabric conditioners, household cleaners and other related items.

Selected articles

Want to see what other hedge funds hold CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Get Rating) .

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)



Get news and reviews for Colgate-Palmolive Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Colgate-Palmolive and related companies with MarketBeat.com’s FREE daily email newsletter.

Leave a Comment